Treatment of Male Pattern Baldness With Botulinum Toxin
Phase 2
Completed
- Conditions
- Male Pattern Baldness
- Registration Number
- NCT00965640
- Lead Sponsor
- The Crown Institute
- Brief Summary
This proof of concept study seeks to demonstrate that Botulinum toxin injections are a safe and effective method for treating this form of hair loss.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- Not specified
Inclusion Criteria
- Male pattern baldness
- Norwood II-VI
Exclusion Criteria
- Treatment with Botulinum toxins or other hair growth interventions with past year
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hair Growth 1 year
- Secondary Outcome Measures
Name Time Method Hair Loss 1 year
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms explain Botulinum Toxin-A's effect on androgenetic alopecia in NCT00965640?
How does Botulinum Toxin-A compare to minoxidil or finasteride in treating male pattern baldness?
Are there specific biomarkers that predict response to Botulinum Toxin-A for androgenetic alopecia?
What adverse events were observed in NCT00965640 and how were they managed?
What combination therapies or alternative compounds show promise alongside Botulinum Toxin for androgenetic alopecia?
Trial Locations
- Locations (1)
Crown Institute
🇨🇦Pickering, Ontario, Canada
Crown Institute🇨🇦Pickering, Ontario, Canada